Antibodies under a microscope

PX-TA1893

Emfizatamab Biosimilar – Anti-CD3e/CD19/CD274/TNFRSF9 mAb – Research Grade

Description

Emfizatamab Biosimilar - Anti-CD3e/CD19/CD274/TNFRSF9 mAb - Research Grade

Target

CD3e/CD19/CD274/TNFRSF9

Target Alias Name

Emfizatamab

Isotype/Mimetic

scFv-G1-scFv-scFv/ L-kappa

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression